HAL vs HROW · P/E 9.3, $19.05B cap vs rev $199.6M
Halliburton Company (HAL) versus Harrow Health Inc (HROW) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported HROW revenue for 2024-12-31 was $199.6M. Net income was -$17.5M. Revenue was up 53.3% from 2023-12-31 to 2024-12-31. HROW currently screens at market cap $1.28B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. HROW currently screens at market cap $1.28B.
Not investment advice. Open the HAL and HROW stock pages for the full models.
Not investment advice.